In 2012, an Italian Named Patient Program began for hepatitis C virus (HCV)-infected liver transplant (LT) recipients with advanced fibrosis, before approval of direct antiviral agents (DAA), to benefit severely ill patients. The aim of this "real-life" study was to assess treatment efficacy and safety with an extended course of daclatasvir (DCV) plus sofosbuvir (SOF) with or without ribavirin (RBV).

Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post-transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study / Lionetti, Raffaella; Calvaruso, Vincenza; Piccolo, Paola; Mancusi, Rossella Letizia; Mazzarelli, Chiara; Fagiuoli, Stefano; Montalbano, Marzia; Lenci, Ilaria; Carrai, Paola; Guaraldi, Giovanni; Visco-Comandini, Ubaldo; Milana, Martina; Biolato, Marco; Loiacono, Laura; Valente, Giovanna; Craxì, Antonio; Angelico, Mario; D'offizi, Gianpiero. - In: CLINICAL TRANSPLANTATION. - ISSN 0902-0063. - 32:2(2018), pp. 1-8. [10.1111/ctr.13165]

Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post-transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study

Guaraldi, Giovanni;
2018

Abstract

In 2012, an Italian Named Patient Program began for hepatitis C virus (HCV)-infected liver transplant (LT) recipients with advanced fibrosis, before approval of direct antiviral agents (DAA), to benefit severely ill patients. The aim of this "real-life" study was to assess treatment efficacy and safety with an extended course of daclatasvir (DCV) plus sofosbuvir (SOF) with or without ribavirin (RBV).
2018
29-nov-2017
32
2
1
8
Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post-transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study / Lionetti, Raffaella; Calvaruso, Vincenza; Piccolo, Paola; Mancusi, Rossella Letizia; Mazzarelli, Chiara; Fagiuoli, Stefano; Montalbano, Marzia; Lenci, Ilaria; Carrai, Paola; Guaraldi, Giovanni; Visco-Comandini, Ubaldo; Milana, Martina; Biolato, Marco; Loiacono, Laura; Valente, Giovanna; Craxì, Antonio; Angelico, Mario; D'offizi, Gianpiero. - In: CLINICAL TRANSPLANTATION. - ISSN 0902-0063. - 32:2(2018), pp. 1-8. [10.1111/ctr.13165]
Lionetti, Raffaella; Calvaruso, Vincenza; Piccolo, Paola; Mancusi, Rossella Letizia; Mazzarelli, Chiara; Fagiuoli, Stefano; Montalbano, Marzia; Lenci,...espandi
File in questo prodotto:
File Dimensione Formato  
2017 Sofosbuvir and daclatasvir.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 776.32 kB
Formato Adobe PDF
776.32 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1152764
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 9
social impact